During the past decade, Centrum Badan Klinicznych S.C. conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 10 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Badan Klinicznych S.C." #1 sponsor was "Galapagos NV" with 5 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Fresenius Kabi SwissBioSim GmbH" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Badan Klinicznych S.C." #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Badan Klinicznych S.C." are "Psoriasis" (4 trials), "Rheumatoid Arthritis" (4 trials), "Active Psoriatic Arthritis" (1 trials), "Ankylosing Spondylitis" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Centrum Badan Klinicznych S.C." in a lesser frequency.

Most popular intervention types in "Centrum Badan Klinicznych S.C." are "Drug" (13 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Filgotinib" (3 trials), "CP-690,550" (2 trials), "GLPG3970" (2 trials) and "Apremilast" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Badan Klinicznych S.C." are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centrum Badan Klinicznych S.C.". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Centrum Badan Klinicznych S.C., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Badan Klinicznych S.C., 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".